Newsletter
GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry
GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry
Newsletter
Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells
Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells
Literature
Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents
SARS-CoV-2 (COVID-19) Research Reagents
Newsletter
Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease
Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease
Literature
Brochure - SARS-CoV-2 (COVID-19) Research
Download the latest version of GeneTex's SARS-CoV-2 (COVID-19) Research brochure.
Newsletter
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
Newsletter
Spike Antibody-mediated Neutralization of SARS-CoV-2
Spike Antibody-mediated Neutralization of SARS-CoV-2
Articles
GeneTex Webinar: SARS-CoV-2 and COVID-19
A World Problem Needing a World Response
Articles
The concept of a SARS-CoV-2 / COVID-19 rapid test
A rapid virus antigen test detects SARS-CoV-2 particles in samples by capturing viral antigen between a free labeled antibody and a fixed second antibody that each recognize different regions of the antigen.
Literature
Flyer - Virus Entry into Host Cells
Download the latest version of GeneTex's Virus entry into host cells flyer.
Literature
Flyer - Cited Antibodies
Download the latest version of GeneTex's cited antibodies flyer.